This model who breastfed on the runway says she's not the one who should make headlines.

Mara Martin was chosen as one of the Sports Illustrated Swim Search finalists just five months after giving birth.

Sports Illustrated named the young mom one of its Sweet 16 finalists during a model search in Miami. But Martin took balancing motherhood and work to another level when she walked the runway while breastfeeding her 5-month-old baby.

The Sports Illustrated Swimsuit Instagram account shared a video of Martin with her baby cradled in her arms, nursing away, with the comment "GIRL POWER!"


Reactions to the video were predictably mixed, but Martin's response to the attention deserves a standing ovation.

Some people felt that seeing a mom breastfeeding unabashedly in public — while doing her job — was an empowering statement. Others, unsurprisingly, found it icky/gross/unattractive/etc. Some simply called it a silly publicity stunt.

But Martin's response to the media frenzy proves that she's just as badass as her fans made her out to be and not just because she fed her baby in an unconventional place.

First, Martin took to Instagram to first explain how breastfeeding is totally normal.

"I can’t believe I am waking up to headlines with me and my daughter in them for doing something I do every day," she wrote. "It is truly so humbling and unreal to say the least. I’m so grateful to be able to share this message and hopefully normalize breastfeeding and also show others that women CAN DO IT ALL!"

Wow! WHAT A NIGHT! Words can’t even describe how amazing I feel after being picked to walk the runway for @si_swimsuit. Anyone who knows me, knows it has been a life long dream of mine. I can’t believe I am waking up to headlines with me and my daughter in them for doing something I do every day. It is truly so humbling and unreal to say the least. I’m so grateful to be able to share this message and hopefully normalize breastfeeding and also show others that women CAN DO IT ALL! But to be honest, the real reason I can’t believe it is a headline is because it shouldn’t be a headline!!! My story of being a mother and feeding her while walking is just that. Last night there are far more deserving headlines that our world should see. One woman is going to boot camp in two weeks to serve our country (sorry i don’t know your IG handle 🤦🏽‍♀️), one woman had a mastectomy (@allynrose), and another is a cancer survivor, 2x paralympic gold medalist, as well as a mother herself (@bren_hucks you rock) Those are the stories that our world should be discussing!!!! Just thinking about all that was represented there... I desperately need to give the most thanks to @mj_day for this. She supported me in what I did last night. Without her support this wouldn’t even be discussed!!!! She and the entire Sports Illustrated family are the most amazing and incredible team to have worked with. THANK YOU for letting all 16 of us be our true selves, strong beautiful women!!! Because of you, my daughter is going to grow up in a better world, where she will always feel this way!!!!!! Lastly, to every single woman that rocked that runway with me. Be proud. I know I am of you! You all have inspired me in ways unimaginable. I love you all!!! #siswimsearch

A post shared by Mara Martin (@_maramartin_) on

"But to be honest, the real reason I can’t believe it is a headline is because it shouldn’t be a headline!!!" she continued. "My story of being a mother and feeding her while walking is just that."

We may not be used to seeing a model on the runway nursing a baby, but that doesn't mean it shouldn't be done. For many breastfeeding moms, nursing on-the-go is a way of life, and not something that needs to be hidden away from the public eye.

Then she directed the attention away from herself and placed it on her deserving colleagues.

"Last night there are far more deserving headlines that our world should see," Martin wrote, before describing the incredible women she shared the stage with. "One woman is going to boot camp in two weeks to serve our country (sorry i don’t know your IG handle 🤦🏽‍♀️), one woman had a mastectomy (@allynrose), and another is a cancer survivor, 2x paralympic gold medalist, as well as a mother herself (@bren_hucks you rock) Those are the stories that our world should be discussing!!!!"

Indeed, some of the women in the Sweet 16 are impressive women. Allyn Rose chose to have a double mastectomy after losing her mother and grandmother to breast cancer, and she gave a TED Talk on "The Power of Redefining Breasts." Brenna Huckaby is a cancer survivor who has won two gold medals in the Paralympics, and is a finalist for ESPN's Athlete with a Disability ESPY award.

Kudos to Mara Martin not only for breastfeeding on the runway but for shining the spotlight on those who have done more consequential things than simply feed a hungry baby.

Wear your values with products from PSA Supply Co., an independent site owned by our parent company, GOOD Worldwide Inc. GOOD makes money when you buy these products, and 10% of profits go to The Center for Community Change Action. Use discount code UPWORTHY to get 15% off your first order!
via Carl Nassib / Instagram

Las Vegas Raiders pass-rush specialist, defensive end Carl Nassib just made a brave announcement for Pride Month. "I just wanted to take a quick moment to say that I'm gay. I've been meaning to do this for a while now but finally feel comfortable getting it off my chest."

The announcement makes Nassib the first active NFL player to be openly gay. What's great about the selfie video is how casually he mentions something that will have a major effect on the world of sports and the lives of countless LGBTQ youth.

In his announcement, he also said that he's giving $100,000 to The Trevor Project, a nonprofit organization that focuses on suicide prevention programs for LGBTQ youth.

Keep Reading Show less
via Carl Nassib / Instagram

Las Vegas Raiders pass-rush specialist, defensive end Carl Nassib just made a brave announcement for Pride Month. "I just wanted to take a quick moment to say that I'm gay. I've been meaning to do this for a while now but finally feel comfortable getting it off my chest."

The announcement makes Nassib the first active NFL player to be openly gay. What's great about the selfie video is how casually he mentions something that will have a major effect on the world of sports and the lives of countless LGBTQ youth.

In his announcement, he also said that he's giving $100,000 to The Trevor Project, a nonprofit organization that focuses on suicide prevention programs for LGBTQ youth.

Keep Reading Show less
True

Each year, an estimated 1.8 million people in the United States are affected by cancer — most commonly cancers of the breast, lung, prostate, and blood cancers such as leukemia. While not everyone overcomes the disease, thanks to science, more people are surviving — and for longer — than ever before in history.

We asked three people whose lives have been impacted by cancer to share their stories – how their lives were changed by the disease, and how they're using that experience to change the future of cancer treatments with the hope that ultimately, in the fight against cancer, science will win. Here's what they had to say.

Celine Ryan, 55, engineer database programmer and mother of five from Detroit, MI

Photo courtesy of Celine Ryan

In September 2013, Celine Ryan woke up from a colonoscopy to some traumatic news. Her gastroenterologist showed her a picture of the cancerous mass they found during the procedure.

Ryan and her husband, Patrick, had scheduled a colonoscopy after discovering some unusual bleeding, so the suspicion she could have cancer was already there. Neither of them, however, were quite prepared for the results to be positive -- or for the treatment to begin so soon. Just two days after learning the news, Ryan had surgery to remove the tumor, part of her bladder, and 17 cancerous lymph nodes. Chemotherapy and radiation soon followed.

Ryan's treatment was rigorous – but in December 2014, she got the devastating news that the cancer, once confined to her colon, had spread to her lungs. Her prognosis, they said, was likely terminal.

But rather than give up hope, Ryan sought support from online research, fellow cancer patients and survivors, and her medical team. When she brought up immunotherapy to her oncologist, he quickly agreed it was the best course of action. Ryan's cancer, like a majority of colon and pancreatic cancers, had been caused by a defect on the gene KRAS, which can result in a very aggressive cancer that is virtually "undruggable." According to the medical literature, the relatively smooth protein structure of the KRAS gene meant that designing inhibitors to bind to surface grooves and treat the cancer has been historically difficult. Through her support systems, Ryan discovered an experimental immunotherapy trial at the National Institutes of Health (NIH) in Bethesda, MD., and called them immediately to see if she was eligible. After months of trying to determine whether she was a suitable candidate for the experimental treatment, Ryan was finally accepted.

The treatment, known as tumor-infiltrating lymphocyte therapy, or TIL, is a testament to how far modern science has evolved. With this therapy, doctors remove a tumor and harvest special immune cells that are found naturally in the tumor. Doctors then grow the cells in a lab over the next several weeks with a protein that promotes rapid TIL growth – and once the cells number into the billions, they are infused back into the patient's body to fight the cancer. On April 1, 2015, Ryan had her tumor removed at the NIH. Two months later, she went inpatient for four weeks to have the team "wash out" her immune system with chemotherapy and infuse the cells – all 148 billion of them – back into her body.

Six weeks after the infusion, Ryan and Patrick went back for a follow-up appointment – and the news they got was stunning: Not only had no new tumors developed, but the six existing tumors in her lungs had shrunk significantly. Less than a year after her cell infusion, in April 2016, the doctors told Ryan news that would have been impossible just a decade earlier: Thanks to the cell infusion, Ryan was now considered NED – no evaluable disease. Her body was cancer-free.

Ryan is still NED today and continuing annual follow-up appointments at the NIH, experiencing things she never dreamed she'd be able to live to see, such as her children's high school and college graduations. She's also donating her blood and cells to the NIH to help them research other potential cancer treatments. "It was an honor to do so," Ryan said of her experience. "I'm just thrilled, and I hope my experience can help a lot more people."

Patrice Lee, PhD, VP of Pharmacology, Toxicology and Exploratory Development at Pfizer

Photo courtesy of Patrice Lee

Patrice Lee got into scientific research in an unconventional way – through the late ocean explorer Jacques Cousteau.

Lee never met Cousteau but her dreams of working with him one day led her to pursue a career in science. Initially, Lee completed an undergraduate degree in marine biology; eventually, her interests changed and she decided to get a dual doctoral degree in physiology and toxicology at Duke University. She now works at Pfizer's R&D site in Boulder, CO (formerly Array BioPharma), leading a group of scientists who determine the safety and efficacy of new oncology drugs.

"Scientists focused on drug discovery and development in the pharmaceutical industry are deeply committed to inventing new therapies to meet unmet needs," Lee says, describing her field of work. "We're driven to achieve new medicines and vaccines as quickly as possible without sacrificing safety."

Among the drugs Lee has helped develop during her career, including cancer therapies, she says around a dozen are currently in development, while nine have received FDA approval — an incredible accomplishment as many scientists spend their careers without seeing their drug make it to market. Lee's team is particularly interested in therapies for brain metastases — something that Lee says is a largely unmet need in cancer research, and something her team is working on from a variety of angles. "Now that we've had rapid success with mRNA vaccine technology, we hope to explore what the future holds when applying this technology to cancers," Lee says.

But while evaluating potential cancer therapies is a professional passion of Lee's, it's also a mission that's deeply personal. "I'm also a breast cancer survivor," she says. "So I've been on the other side of things and have participated in a clinical trial."

However, seeing how melanoma therapies that she helped develop have affected other real-life cancer patients, she says, has been a highlight of her career. "We had one therapy that was approved for patients with BRAF-mutant metastatic melanoma," Lee recalls. "Our team in Boulder was graced by a visit from a patient that had benefited from these drugs that we developed. It was a very special moment for the entire team."

None of these therapies would be available, Lee says without rigorous science behind it: "Facts come from good science. Facts will drive the development of new drugs, and that's what will help patients."

Chiuying "Cynthia" Kuk (they/them) MS, 34, third-year medical student at Michigan State University College of Human Medicine

Photo courtesy of Cynthia Kuk

Cynthia Kuk was just 10 years old when they had a conversation that would change their life forever.

"My mother, who worked as a translator for the government at the time, had been diagnosed with breast cancer, and after her chemotherapy treatments she would get really sick," Kuk, who uses they/them pronouns, recalls. "When I asked my dad why mom was puking so much, he said it was because of the medicine she was taking that would help her get better."

Kuk's response was immediate: "That's so stupid! Why would a medicine make you feel worse instead of better? When I'm older, I want to create medicine that won't make people sick like that."

Nine years later, Kuk traveled from their native Hong Kong to the United States to do exactly that. Kuk enrolled in a small, liberal arts college for their Bachelor's degree, and then four years later started a PhD program in cancer research. Although Kuk's mother was in remission from her cancer at the time, Kuk's goal was the same as it had been as a 10-year-old watching her suffer through chemotherapy: to design a better cancer treatment, and change the landscape of cancer research forever.

Since then, Kuk's mission has changed slightly.

"My mom's cancer relapsed in 2008, and she ended up passing away about five years after that," Kuk says. "After my mom died, I started having this sense of urgency. Cancer research is such that you work for twenty years, and at the end of it you might have a fancy medication that could help people, but I wanted to help people now." With their mother still at the forefront of their mind, Kuk decided to quit their PhD program and enter medical school.

Now, Kuk plans to pursue a career in emergency medicine – not only because they are drawn to the excitement of the emergency room, but because the ER is a place where the most marginalized people tend to seek care.

"I have a special interest in the LGBTQ+ population, as I identify as queer and nonbinary," says Kuk. "A lot of people in this community and other marginalized communities access care through the ER and also tend to avoid medical care since there is a history of mistreatment and judgement from healthcare workers. How you carry yourself as a doctor, your compassion, that can make a huge difference in someone's care."

In addition to making a difference in the lives of LGBTQ+ patients, Kuk wants to make a difference in the lives of patients with cancer as well, like their mother had.

"We've diagnosed patients in the Emergency Department with cancer before," Kuk says. "I can't make cancer good news but how you deliver bad news and the compassion you show could make a world of difference to that patient and their family."

During their training, Kuk advocates for patients by delivering compassionate and inclusive care, whether they happen to have cancer or not. In addition to emphasizing their patient's pronouns and chosen names, they ask for inclusive social and sexual histories as well as using gender neutral language. In doing this, they hope to make medicine as a whole more accessible for people who have been historically pushed aside.

"I'm just one person, and I can't force everyone to respect you, if you're marginalized," Kuk says. "But I do want to push for a culture where people appreciate others who are different from them."